Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Mark R. Laftavi"'
Autor:
Mahmoudreza Moein, Praise E. Njoku Austin, Rauf Shahbazov, Matthew Hanlon, Alex Almonte, Oleh Pankewycz, Mark R. Laftavi, Reza F. Saidi
Publikováno v:
Surgery in Practice and Science, Vol 13, Iss , Pp 100175- (2023)
Background: The deceased donor kidney allocation system (KAS) aims to optimize and equalize organ access for candidates nationwide and facilitate organ matching for candidates who are harder to match due to biological reasons. In March 2021, UNOS imp
Externí odkaz:
https://doaj.org/article/d0f318cb7b4c48e3870e74eadeca60bc
Autor:
Mahmoudreza Moein, Praise E. Njoku Austin, Rauf Shabazov, Mathew Hanlon, Alex Almonte, Oleh Pankewycz, Mark R. Laftavi, Reza Saidi
Publikováno v:
Transplantation. 106:S675-S676
Autor:
Angelika C. Gruessner, Mark R. Laftavi, Engin Onan, Dane Rucker, O. Pankewycz, Dongliang Wang, Rainer W.G. Gruessner
Publikováno v:
Clinical Transplantation. 34
Background Drug dosing for Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) after kidney transplantation remains challenging. Therapeutic drug monitoring (TDM) offers a means to individualize drug dosing and improve outcomes. Methods In this observat
Publikováno v:
Current Opinion in Organ Transplantation. 22:389-397
Purpose of review The surgical techniques of pancreas transplantation have been evolving and significantly improved over time. This article discusses different current techniques and their modifications. Recent finding At this time, the most commonly
Autor:
Aleksandar Popovic, Nick Huang, Oleh Pankewycz, Christine Yang, Rauf Shahbazov, Allen J Hoste, Mark R. Laftavi, Kathleen Heslin
Publikováno v:
Transplantation. 104:S364-S364
Autor:
Oleh Pankewycz, Reza F. Saidi, Rauf Shahbazov, Mark R. Laftavi, John E. Leggat, Sri Narsipur, Brian J. Gallay
Publikováno v:
Transplantation. 104:S571-S571
Publikováno v:
Current Diabetes Reports. 17
Pancreas transplantation remains the best long-term treatment option to achieve euglycemia and freedom from insulin in patients with labile diabetes mellitus. It is an approved procedure for type 1 (T1DM), but it is still considered controversial for
Autor:
Lin Feng, Karim M Soliman, Sunil Patel, M. Said, Emad Mogadam, Mark R. Laftavi, Oleh Pankewycz
Publikováno v:
Immunological Investigations. 43:819-828
Long-term outcomes following renal transplantation remain limited due to chronic progressive injury partly as a result of calcineurin inhibitor (CNI) toxicity. Thus, patients have been converted to non-CNI immunosuppressives despite the lack of evide
Publikováno v:
Immunological Investigations. 43:775-789
Historically, cellular rather than humoral immunity has gathered the most attention in kidney transplantation. As the specter of cellular acute rejection and early graft loss has faded due to the availability of highly effective immunosuppressive the
Publikováno v:
Immunological Investigations. 43:790-806
Transplant science has improved significantly over the last decade. Influenced by novel advancements, rejection rates and short-term graft losses diminished substantially. Induction therapy was shown to reduce rejection rates and improve short-term g